![FY 2022 Q2 Earnings Trend Down, but Much Less than Predicted](https://www.g2intelligence.com/wp-content/uploads/2022/08/Sept22.LIR_.EarningsReports2022.Q2-iStock-1800x1250-1-1080x675.jpg)
FY 2022 Q2 Earnings Trend Down, but Much Less than Predicted
While not nearly as robust as a year ago, diagnostic companies’ revenues held up surprisingly well in Q2 2022.
While not nearly as robust as a year ago, diagnostic companies’ revenues held up surprisingly well in Q2 2022.
Independent labs accrued a profit of at least $10 on each PCR COVID-19 test performed in the period from May to December 2020, study says.
The UK-based diagnostics firm received CE marks for a diabetes test, CHF test, as well as an analyzer, and two COVID-19 tests.
Most diagnostics companies experienced modest, flat, or negative top-line revenue growth rates in the first quarter of 2022.
HHS will distribute OraSure’s InteliSwab COVID-19 rapid at-home antigen test kits to schools across the nation.